Skip to main content
. Author manuscript; available in PMC: 2010 Nov 9.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2007 Nov 26;71(1):9–15. doi: 10.1016/j.ijrobp.2007.09.033

Fig. 2.

Fig. 2

Kaplan Meier estimates (13) of prostate-specific antigen failure-free survival (11) stratified by the presence or absence of endorectal magnetic resonance imaging–defined tumor progression during neoadjuvant androgen suppression therapy. Log–rank p value = 0.06.